Tocilizumab
Tocilizumab | |
---|---|
Term | Tocilizumab |
Short definition | Tocilizumab - (pronounced) (toh-sih-LIH-zoo-mab) drug used to treat adults and children 2 years and older with severe or life-threatening cytokine release syndrome caused by a type of immunotherapy called chimeric antigen receptor (CAR) T-cell therapy. Tocilizumab is also used to treat certain types of arthritis and a disease that causes inflammation of the lining of the arteries. |
Type | Cancer terms |
Specialty | Oncology |
Language | English |
Source | NCI |
Comments |
Tocilizumab - (pronounced) (toh-sih-LIH-zoo-mab) drug used to treat adults and children 2 years and older with severe or life-threatening cytokine release syndrome caused by a type of immunotherapy called chimeric antigen receptor (CAR) T-cell therapy. Tocilizumab is also used to treat certain types of arthritis and a disease that causes inflammation of the lining of the arteries. It is also being studied in the treatment of other conditions. Tocilizumab attaches to receptors for a protein called interleukin-6 (IL-6), which is made by white blood cells and other cells in the body. This can help lower the body's immune response and reduce inflammation. Tocilizumab is a type of monoclonal antibody. Also called Actemra
External links
- Medical encyclopedia article on Tocilizumab
- Wikipedia's article - Tocilizumab
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski